Capra Biosciences
Capra Biosciences is a startup headquartered in Manassas, United States, founded in 2020. It has raised at least $3.9m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Capra Biosciences has raised at least $3.9m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Capra Biosciences sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.
Other startups in Manassas
Related
Questions and answers
What does Capra Biosciences do?
Capra Biosciences is classed in technology in its filings with the US Securities and Exchange Commission.
How much has Capra Biosciences raised?
At least $3.9m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Capra Biosciences based?
Capra Biosciences is headquartered in Manassas, United States.
When was Capra Biosciences founded?
Capra Biosciences was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.